Guanylyl cyclase C ameliorates visceral pain: an unsuspected link
Visceral pain associated with irritable bowel syndrome afflicts 15% of the US population. Although treatments are limited, guanylyl cyclase C (GUCY2C) agonists alleviate pain and constipation. Until now, it was assumed that the activation of GUCY2C and production of cGMP in enterocytes stimulated fl...
Main Author: | Rodger A. Liddle |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2023-02-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI166703 |
Similar Items
-
Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor.
by: Kerstin Y Beste, et al.
Published: (2013-01-01) -
Guanylyl cyclase C prevents colon carcinoma cell metastasis.
by: Lubbe, W, et al.
Published: (2005) -
Consistent expression of guanylyl cyclase-C in primary and metastatic gastrointestinal cancers.
by: Hadi Danaee, et al.
Published: (2017-01-01) -
Targeting Soluble Guanylyl Cyclase during Ischemia and Reperfusion
by: Eric H. Mace, et al.
Published: (2023-07-01) -
Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis
by: Pitari GM
Published: (2013-04-01)